Exploring the early stages of Alzheimer's disease (AD) is crucial for timely intervention to help manage symptoms and set expectations for affected individuals and their families. However, the study of the early stages of AD involves analysing heterogeneous disease cohorts which may present challenges for some modelling techniques. This heterogeneity stems from the diverse nature of AD itself, as well as the inclusion of undiagnosed or 'at-risk' AD individuals or the presence of comorbidities which differentially affect AD biomarkers within the cohort. Normative modelling is an emerging technique for studying heterogeneous disorders that can quantify how brain imaging-based measures of individuals deviate from a healthy population. The normative model provides a statistical description of the 'normal' range that can be used at subject level to detect deviations, which may relate to pathological effects. In this work, we applied a deep learning-based normative model, pre-trained on MRI scans in the UK Biobank, to investigate ageing and identify abnormal age-related decline. We calculated deviations, relative to the healthy population, in multi-modal MRI data of non-demented individuals in the external EPAD (ep-ad.org) cohort and explored these deviations with the aim of determining whether normative modelling could detect AD-relevant subtle differences between individuals. We found that aggregate measures of deviation based on the entire brain correlated with measures of cognitive ability and biological phenotypes, indicating the effectiveness of a general deviation metric in identifying AD-related differences among individuals. We then explored deviations in individual imaging features, stratified by cognitive performance and genetic risk, across different brain regions and found that the brain regions showing deviations corresponded to those affected by AD such as the hippocampus. Finally, we found that 'at-risk' individuals in the EPAD cohort exhibited increasing deviation over time, with an approximately 6.4 times greater t-statistic in a pairwise t-test compared to a 'super-healthy' cohort. This study highlights the capability of deep normative modelling approaches to detect subtle differences in brain morphology among individuals at risk of developing AD in a non-demented population. Our findings allude to the potential utility of normative deviation metrics in monitoring disease progression.

Segmentation is one of the most significant steps in image processing. Segmenting an image is a technique that makes it possible to separate a digital image into various areas based on the different characteristics of pixels in the image. In particular, the segmentation of breast ultrasound images is widely used for cancer identification. As a result of image segmentation, it is possible to make early diagnoses of a diseases via medical images in a very effective way. Due to various ultrasound artifacts and noises, including speckle noise, low signal-to-noise ratio, and intensity heterogeneity, the process of accurately segmenting medical images, such as ultrasound images, is still a challenging task. In this paper, we present a new method to improve the accuracy and effectiveness of breast ultrasound image segmentation. More precisely, we propose a neural network (NN) based on U-Net and an encoder-decoder architecture. By taking U-Net as the basis, both the encoder and decoder parts are developed by combining U-Net with other deep neural networks (Res-Net and MultiResUNet) and introducing a new approach and block (Co-Block), which preserve as much as possible the low-level and the high-level features. The designed network is evaluated using the Breast Ultrasound Images (BUSI) Dataset. It consists of 780 images, and the images are categorized into three classes, which are normal, benign, and malignant. According to our extensive evaluations on a public breast ultrasound dataset, the designed network segments the breast lesions more accurately than other state-of-the-art deep learning methods. With only 8.88 M parameters, our network (CResU-Net) obtained 82.88%, 77.5%, 90.3%, and 98.4% in terms of Dice similarity coefficients (DSC), intersection over union (IoU), area under curve (AUC), and global accuracy (ACC), respectively, on the BUSI dataset.

Sparse-view CT reconstruction is a challenging ill-posed inverse problem, where insufficient projection data leads to degraded image quality with increased noise and artifacts. Recent deep learning approaches have shown promising results in CT reconstruction. However, existing methods often neglect projection data constraints and rely heavily on convolutional neural networks, resulting in limited feature extraction capabilities and inadequate adaptability. To address these limitations, we propose a Dual-domain deep Prior-guided Multi-scale fusion Attention (DPMA) model for sparse-view CT reconstruction, aiming to enhance reconstruction accuracy while ensuring data consistency and stability. First, we establish a residual regularization strategy that applies constraints on the difference between the prior image and target image, effectively integrating deep learning-based priors with model-based optimization. Second, we develop a multi-scale fusion attention mechanism that employs parallel pathways to simultaneously model global context, regional dependencies, and local details in a unified framework. Third, we incorporate a physics-informed consistency module based on range-null space decomposition to ensure adherence to projection data constraints. Experimental results demonstrate that DPMA achieves improved reconstruction quality compared to existing approaches, particularly in noise suppression, artifact reduction, and fine detail preservation.

Minimally invasive surgery involves entering the body through small incisions or natural orifices, using a medical endoscope for observation and clinical procedures. However, traditional endoscopic images often suffer from low texture and uneven illumination, which can negatively impact surgical and diagnostic outcomes. To address these challenges, many researchers have applied deep learning methods to enhance the processing of endoscopic images. This paper proposes a monocular medical endoscopic image depth estimation method based on a window-adaptive asymmetric dual-branch Siamese network. In this network, one branch focuses on processing global image information, while the other branch concentrates on local details. An improved lightweight Squeeze-and-Excitation (SE) module is added to the final layer of each branch, dynamically adjusting the inter-channel weights through self-attention. The outputs from both branches are then integrated using a lightweight cross-attention feature fusion module, enabling cross-branch feature interaction and enhancing the overall feature representation capability of the network. Extensive ablation and comparative experiments were conducted on medical datasets (EAD2019, Hamlyn, M2caiSeg, UCL) and a non-medical dataset (NYUDepthV2), with both qualitative and quantitative results-measured in terms of RMSE, AbsRel, FLOPs and running time-demonstrating the superiority of the proposed model. Additionally, comparisons with CT images show good organ boundary matching capability, highlighting the potential of our method for clinical applications. The key code of this paper is available at: https://github.com/superchongcnn/AttenAdapt_DE .

Deep learning models hold significant promise for disease diagnosis but often lack transparency in their decision-making processes, limiting trust and hindering clinical adoption. This study introduces a novel multi-task learning framework to enhance the medical explainability of deep learning models for diagnosing age-related macular degeneration (AMD) using fundus images. The framework simultaneously performs AMD classification and lesion segmentation, allowing the model to support its diagnoses with AMD-associated lesions identified through segmentation. In addition, we perform an in-depth interpretability analysis of the model, proposing the Medical Explainability Index (MXI), a novel metric that quantifies the medical relevance of the generated heatmaps by comparing them with the model's lesion segmentation output. This metric provides a measurable basis to evaluate whether the model's decisions are grounded in clinically meaningful information. The proposed method was trained and evaluated on the Automatic Detection Challenge on Age-Related Macular Degeneration (ADAM) dataset. Experimental results demonstrate robust performance, achieving an area under the curve (AUC) of 0.96 for classification and a Dice similarity coefficient (DSC) of 0.59 for segmentation, outperforming single-task models. By offering interpretable and clinically relevant insights, our approach aims to foster greater trust in AI-driven disease diagnosis and facilitate its adoption in clinical practice.

We developed and validated a magnetic resonance imaging (MRI)-based radiomics model for the classification of high-grade glioma (HGG) and determined the optimal machine learning (ML) approach. This retrospective analysis included 184 patients (59 grade III lesions and 125 grade IV lesions). Radiomics features were extracted from MRI with T1-weighted imaging (T1WI). The least absolute shrinkage and selection operator (LASSO) feature selection method and seven classification methods including logistic regression, XGBoost, Decision Tree, Random Forest (RF), Adaboost, Gradient Boosting Decision Tree, and Stacking fusion model were used to differentiate HGG. Performance was compared on AUC, sensitivity, accuracy, precision and specificity. In the non-fusion models, the best performance was achieved by using the XGBoost classifier, and using SMOTE to deal with the data imbalance to improve the performance of all the classifiers. The Stacking fusion model performed the best, with an AUC = 0.95 (sensitivity of 0.84; accuracy of 0.85; F1 score of 0.85). MRI-based quantitative radiomics features have good performance in identifying the classification of HGG. The XGBoost method outperforms the classifiers in the non-fusion model and the Stacking fusion model outperforms the non-fusion model.

Glioblastoma (GBM) is the most aggressive adult primary brain cancer, characterized by significant heterogeneity, posing challenges for patient management, treatment planning, and clinical trial stratification. We developed a highly reproducible, personalized prognostication, and clinical subgrouping system using machine learning (ML) on routine clinical data, magnetic resonance imaging (MRI), and molecular measures from 2838 demographically diverse patients across 22 institutions and 3 continents. Patients were stratified into favorable, intermediate, and poor prognostic subgroups (I, II, and III) using Kaplan-Meier analysis (Cox proportional model and hazard ratios [HR]). The ML model stratified patients into distinct prognostic subgroups with HRs between subgroups I-II and I-III of 1.62 (95% CI: 1.43-1.84, P < .001) and 3.48 (95% CI: 2.94-4.11, P < .001), respectively. Analysis of imaging features revealed several tumor properties contributing unique prognostic value, supporting the feasibility of a generalizable prognostic classification system in a diverse cohort. Our ML model demonstrates extensive reproducibility and online accessibility, utilizing routine imaging data rather than complex imaging protocols. This platform offers a unique approach to personalized patient management and clinical trial stratification in GBM.

In this study, we attempted to identify the subtypes of autism spectrum disorder (ASD) with the help of anatomical alterations found in structural magnetic resonance imaging (sMRI) data of the ASD brain and machine learning tools. Initially, the sMRI data was preprocessed using the FreeSurfer toolbox. Further, the brain regions were segmented into 148 regions of interest using the Destrieux atlas. Features such as volume, thickness, surface area, and mean curvature were extracted for each brain region. We performed principal component analysis independently on the volume, thickness, surface area, and mean curvature features and identified the top 10 features. Further, we applied k-means clustering on these top 10 features and validated the number of clusters using Elbow and Silhouette method. Our study identified two clusters in the dataset which significantly shows the existence of two subtypes in ASD. We identified the features such as volume of scaled lh_G_front middle, thickness of scaled rh_S_temporal transverse, area of scaled lh_S_temporal sup, and mean curvature of scaled lh_G_precentral as the significant features discriminating the two clusters with statistically significant p-value (p<0.05). Thus, our proposed method is effective for the identification of ASD subtypes and can also be useful for the screening of other similar neurological disorders.

Artificial intelligence (AI) has transformed medical diagnostics by enhancing the accuracy of disease detection, particularly through deep learning models to analyze medical imaging data. However, the energy demands of training these models, such as ResNet and MobileNet, are substantial and often overlooked; however, researchers mainly focus on improving model accuracy. This study compares the energy use of these two models for classifying thoracic diseases using the well-known CheXpert dataset. We calculate power and energy consumption during training using the EnergyEfficientAI library. Results demonstrate that MobileNet outperforms ResNet by consuming less power and completing training faster, resulting in lower overall energy costs. This study highlights the importance of prioritizing energy efficiency in AI model development, promoting sustainable, eco-friendly approaches to advance medical diagnosis.

Employing a whole-brain (WB) mask as a region of interest for extracting radiomic features is a feasible, albeit less common, approach in neuro-oncology research. This study aims to evaluate the relationship between WB radiomic features, derived from various neuroimaging modalities in patients with gliomas, and some key baseline characteristics of patients and tumors such as sex, histological tumor type, WHO Grade (2021), IDH1 mutation status, necrosis lesions, contrast enhancement, T/N peak value and metabolic tumor volume. Forty-one patients (average age 50 ± 15 years, 21 females and 20 males) with supratentorial glial tumors were enrolled in this study. A total of 38,720 radiomic features were extracted. Cluster analysis revealed that whole-brain images of biologically different tumors could be distinguished to a certain extent based on their imaging biomarkers. Machine learning capabilities to detect image properties like contrast-enhanced or necrotic zones validated radiomic features in objectifying image semantics. Furthermore, the predictive capability of imaging biomarkers in determining tumor histology, grade and mutation type underscores their diagnostic potential. Whole-brain radiomics using multimodal neuroimaging data appeared to be informative in neuro-oncology, making research in this area well justified.